There's no way out of this bagger club period. This group

New Post Public Reply Private Reply Replies (0) Message Board
Sawbuckle holsh #758

There's no way out of this bagger club period. This group has but one mandate and believe me, it's not too create and or market a real company. Even when the R/S happens, it's still a scam and no amount of rinsing and repeating is going to make any one any measurable amount of positive bank; except for, these crooks. In my camp there are a lot of questions these doosh bags refuse to answer and they're not answers protected by the SEC or any other insider regulatory rules. They're answers which; IMO, would either exonerate them or incriminate them in any wrong doings and or fraud. There's been a lot of pr's stretching the truth and a lot of cash generated and hidden by these jokers. I would bet if the right people starting asking about the Houdini cash and proof of where it went and or come by, including proof of pr content over the years (namely proof and names of individuals whom had allegedly offered any term sheet proposals) these reptiles would be slithering away to hid under some very remote rocks.

I and my group fully expect huge losses from this listing, which depending on this years success or failure, may be used to offset any profits on some real stocks/investments.

Farfetch Limited (FTCHQ) Stock Research Links

FTCHQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 2

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 4

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 9

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 8

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 8

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 5

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 9

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 5

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Insight: What to Expect from PulteGroup This Quarter

Updated Category News Views 161

PulteGroup's Earnings Release: What Investors Should Anticipate PulteGroup (PHM) is set to reveal its quarterly earnings, creating a buzz among investors and analysts alike. As we gear up for this important announcement, let’s dive into the essential details and what to expect. Analysts' Predictions for PulteGroup Expectations are high for PulteGroup as analysts...

Continue Reading
ReShape Lifesciences Implements Cost Strategies and Merger Updates

Updated Category News Views 278

ReShape Lifesciences Focuses on Cost Efficiency and Growth In a strategic move to enhance operational efficiency, ReShape Lifesciences Inc. (NASDAQ: RSLS), a leader in weight loss and metabolic health solutions, has announced significant cost reduction measures aimed at saving over $750,000, which represents 23% of their annual payroll. This decision comes as part of a...

Continue Reading
Understanding the Recent Decline in StubHub's Stock Prices

Updated Category News Views 349

StubHub's Recent Stock Performance StubHub Holdings, Inc. (NYSE: STUB) saw a significant drop in its stock prices recently, prompting investors to take note. The company disclosed disappointing third-quarter earnings, which led to multiple analysts adjusting their price targets downward. Third-Quarter Earnings Overview The company reported a loss of $4.27 per share,...

Continue Reading
Nutex Health Prepares for Earnings Call – Key Insights Ahead

Updated Category News Views 379

All Eyes on Nutex Health's Upcoming Earnings Call Forget the fluffy talk—Nutex Health is about to drop some serious numbers. They’ve got their annual report gearing up for March, and you better believe the market’s going to be stewing over this one. The earnings report for the fiscal year ending December 31, 2025, is set to hit right after market close on March 5,...

Continue Reading
Cellectis Showcases Innovations in Non-Viral Gene Therapy at Congress

Updated Category News Views 210

Exciting Advances in Gene Therapy by Cellectis Cellectis, a clinical-stage biotechnology company, is making headlines with its innovative approach to gene therapy, particularly in the exciting world of gene editing. Recently, the company announced significant findings regarding the potential of circular single-stranded DNA (CssDNA) as a universal non-viral template for...

Continue Reading